N1 Single lymph node metastasis, 2 cm or less in greatest ... The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% ...

Given different scientific and clinical meeting schedules, considering advances in genitourinary oncology in novel therapies ...

Natera, Inc. , a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the HEROES clinical trial. HEROES is a multi-center, phase II trial that ...

Over the last years, many biological markers emerged that act as an adjunct for the detection of early bladder cancer recurrence. Some of these markers had a proven better sensitivity and ...

Along with its UC indication, Trodelvy is also FDA-approved for previously treated metastatic triple-negative ... treatment for non-muscle-invasive bladder cancer (NMIBC).

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

New research has revealed genetic differences between Black and White patients with metastatic breast cancer as well as a treatment difference that is not explained by genetic differences.

The researchers had previously found 15 genes in mice that had an effect on cancer metastasis. They found that mice lacking a gene which produces a protein called ARHGEF1 had less metastasis of ...

I also have 2 tumors in my lung. These are all metastases of my melanoma. Unfortunately, the website also notes, “Metastatic cancer is usually harder to treat than cancer that hasn’t spread.” The ...

HEROES is Natera's first clinical trial using Signatera to guide de-escalation of therapy in patients with metastatic HER2+ breast cancer Approximately 170 patients are expected to enroll in up ...

In a groundbreaking clinical trial, immunotherapy alone eliminated rectal cancer in all 14 participants. This study, the ...